Top San Francisco Bay Area, CA Health Tech Companies With Best Stability & Growth (606)
Headway’s mission is a big one – to build a new mental health care system everyone can access. We’ve built technology that helps people find great therapists with the first software-enabled national network of providers accepting insurance. 1 in 4 people in the US have a treatable mental health condition, but the majority of providers don’t accept insurance, making therapy...
Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. Our network members include over 80% of U.S. physicians across all states and every medical specialty. Our mission is to help every physician be more productive and provide better care for their patients. We are physicians-first, putting technology to work for doctors instead of the other way around....
.jpg)
We're Mochi Health, a pioneering force in obesity medicine dedicated to building personalized, clinically-backed weight care solutions. We're on a mission to empower patients with one-on-one virtual care and proven pharmaceutical treatments. We recognize that every body is unique, and believe weight loss plans should be, too. With over 100 million individuals struggling with obesity and 15 million already using GLP-1 prescriptions,...
Mochi Health's Top Stability & Growth Strengths
Market Expansion: Market Expansion: Nationwide telehealth availability and launches into additional categories beyond obesity care indicate an expanding geographic and service footprint. Company posts and event sponsorships reinforce ongoing outreach consistent with a scale-up trajectory.
Product Line Growth: Product Line Growth: An actively updated iOS app and refreshed online platform, together with new specialty areas, show continued investment in product and service breadth. The organization appears to be evolving from a single-category clinic toward a broader digital health offering.
Strong Hiring & Retention: Strong Hiring & Retention: Frequent role postings on professional networks and visible employer-brand activity point to active headcount growth. Hiring across functions such as marketing and design suggests support capabilities are being built alongside core clinical and product teams.
.png)
Artera, a SaaS leader in digital health, transforms patient experience with AI-powered virtual agents (voice and text) for every step of the patient journey. Trusted by 1,000+ provider organizations — including specialty groups, FQHCs, large IDNs and federal agencies — engaging 100 million patients annually. Artera’s virtual agents support front desk staff to improve patient access including self-scheduling, intake, forms,...
Artera's Top Stability & Growth Strengths
Strong Revenue Growth: Company announcements indicate it surpassed $100M in contracted annual recurring revenue by the end of 2025. This milestone, alongside repeated inclusion on high‑growth company lists, points to accelerating top‑line momentum.
Investor Backing & Capital Strength: A $65M growth investment led by Lead Edge Capital was disclosed to accelerate AI agent capabilities and expansion. This fresh capital provides additional resources to scale product and distribution.
Strong Market Position & Advantage: Artera was named #1 Best in KLAS for Patient Communications in 2026, reinforcing adoption and satisfaction signals in its category. Disclosures cite 1,000+ healthcare organizations and billions of annual patient communications, evidencing broad footprint.
.png)
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is using the power of high-intensity sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to enhance the scientific understanding of cancer biology, and to develop and commercialize pioneering products.
.png)
We see technology not as a layer on top of care, but as the connective tissue that helps it grow. Grow Therapy is an online therapy platform that helps you find a therapist who gets you—and takes your insurance. Grow was founded to create end-to-end systems that make therapy easier on both sides: helping therapists launch and grow thriving private practices...
Grow Therapy's Top Stability & Growth Strengths
Investor Backing & Capital Strength: A $150 million Series D at around a $3 billion valuation signals strong investor confidence and provides resources to fund expansion. A favorable funding environment in behavioral health further supports access to capital for scaled platforms.
Strong Revenue Growth: Reported approximately $1 billion in annual revenue alongside 7 million visits in 2025 and 10 million cumulative appointments indicate substantial monetized usage. These utilization and revenue figures point to rapid scale-up over recent years.
Strategic Partnerships: Integrations with 125+ health plans and expansion into employer benefits and health system partnerships broaden distribution beyond the original marketplace. This multi-channel buildout reduces reliance on a single route to market and opens additional growth avenues.
At Freed, we’re on a mission to give clinicians their time back - because healthcare professionals should be caring for patients, not drowning in paperwork. Every year, doctors and clinicians spend thousands of hours documenting care. That’s time lost to late nights, burnout, and administrative overload. Freed is changing that. We’ve built a powerful, AI-driven medical scribe that listens in on...
Freed's Top Stability & Growth Strengths
Investor Backing & Capital Strength: A $30M Series A led by Sequoia Capital (March 5, 2025) and visible hiring/office expansion signal access to capital supporting scale. Active job postings and a larger San Francisco office with capacity for 65+ teammates reinforce ongoing investment.
Strong Revenue Growth: Independent estimates and company communications point to ARR around the high–teens to $20M range by spring 2025 with rapid year-over-year increases. Rising clinician counts (e.g., “26,000+” cited in April 2026 materials) align with this momentum.
Product Line Growth: The April 2026 launch of “Freed Front Desk” with published pricing, alongside coding, pre‑charting, templates, and EHR push features, shows expansion beyond a single scribe product. Claims of significant hold‑time reduction and broader workflow coverage indicate movement into adjacent front‑office functions.
.png)
American medicine is the best in the world. But the American healthcare system is challenged by high administrative costs that burden patients, health systems, and insurance companies with unnecessary expenses. We are focused on addressing those challenges. We use GenAI to improve the most pressing financial pain points in the revenue cycle. We’re one of the first companies to deploy GenAI...
AKASA's Top Stability & Growth Strengths
Investor Backing & Capital Strength: A $120M funding round announced on June 18, 2024 is highlighted as a strong proxy for expansion capacity. TechCrunch’s year-end recap lists AKASA among U.S. AI startups that raised $100M+ in 2024.
Strategic Partnerships: Cleveland Clinic rolled out AKASA’s AI coding tools systemwide in early 2025 and expanded to a CDI solution across all U.S. locations by October 13, 2025. An Oracle Cerner collaboration broadens access to AKASA’s automation for EHR customers.
Market Expansion: AKASA’s site states its client base represents 650+ hospitals and 6,500+ outpatient facilities across all 50 states. Named customer outcomes such as Nebraska Methodist’s reported $2M+ gross revenue lift and the upsell within Cleveland Clinic indicate footprint growth and upsell potential.
ZS is a management consulting and technology firm that partners with companies to improve life and how we live it. We transform ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 15,000+ employees in over 40 offices worldwide.
ZS's Top Stability & Growth Strengths
Market Expansion: Headcount and office disclosures show an expansion from 35+ to 40+ offices, alongside new capacity such as the Hyderabad Operations Center. These moves indicate a broader global presence to meet demand.
Strong Hiring & Retention: Recent materials cite 2,783 new hires in 2024 and over 2,850 promotions, with labor‑market analytics indicating year‑over‑year headcount growth through 2025. These suggest sustained talent investment and scaling.
Innovation-Driven Growth: Creation of a dedicated Platform & Products unit and scaling of ZAIDYN/Max.AI signal a push toward scalable, AI‑enabled offerings. Acquisitions such as Digital Additive (2024) and Torrent Consulting (2025) further broaden Salesforce and AI capabilities.
EliseAI builds vertical AI agents for housing and healthcare — sectors that together make up nearly 40% of household spending. These agents automate high-volume workflows like leasing, maintenance, renewals, and patient intake, helping organizations cut costs, improve efficiency, and deliver better experiences. How does it work? EliseAI integrates directly into operational workflows: Housing: Manages leasing, maintenance, renewals, billing, and resident communication. Healthcare: Handles intake,...
EliseAI's Top Stability & Growth Strengths
Investor Backing & Capital Strength: Recent late-stage funding rounds and a higher valuation are presented as clear signals of substantial capital support and investor confidence. The company indicates plans to deploy this capital toward team growth and product development across core markets.
Strong Revenue Growth: Management reports crossing a major ARR milestone with multiple years of rapid top-line expansion. Consistent year-over-year acceleration is highlighted alongside continued scaling plans.
Market Expansion: The business is extending beyond housing into healthcare and signaling international ambitions. New office hubs and active hiring across functions support broader geographic and vertical reach.
Collectly is a fast-growing healthcare tech startup leading the charge in transforming the U.S. healthcare market through AI-driven innovation. In the U.S., millions of patients interact with healthcare providers daily, navigating a system that often struggles with inefficiencies, administrative burdens, and suboptimal financial experiences. At the forefront of the AI boom, Collectly is redefining revenue cycle management (RCM) by applying cutting-edge...
Collectly's Top Stability & Growth Strengths
Investor Backing & Capital Strength: Funding of a $29M Series A led by Sapphire Ventures is presented as providing resources to scale product and go-to-market. This capital raise is cited alongside ongoing hiring and expansion activities.
Product Line Growth: Launches of the 'Billie' AI agent for billing and later eligibility features, followed by the 2026 Pledge Health acquisition, are described as broadening the platform and extending automation into pre-service workflows. These moves expand the upsell surface and end-to-end coverage.
Market Expansion: Partnerships such as being named a preferred partner by CentralReach and references to use across 3,000+ facilities indicate meaningful penetration and distribution. Company communications also highlight rising daily patient engagement and active recruiting as demand signals.
At Sprinter Health, we're focused on dramatically expanding access to healthcare by reimagining the patient experience—delivered at home and powered by technology for scale. We’re a boots-on-the-ground clinician network for the tele-health age, bringing routine blood draws, labs, and vitals checks into people's busy lives. We have completed over 140,000 appointments in 2025 across the US!
Sprinter Health's Top Stability & Growth Strengths
Strong Revenue Growth: The company reports sharply increasing revenue year over year alongside expanding operations. This indicates accelerating commercial momentum with national health plans.
Investor Backing & Capital Strength: The company has secured substantial funding from prominent investors, including a recent Series B, to fuel technology and market expansion. This capital position supports continued scaling across teams and geographies.
Market Expansion: The company has rapidly grown its multi-state footprint and reached significant in-home visit volume. Feedback suggests this reflects repeatable execution across diverse markets and populations.
We bring together one of the world’s largest libraries of multimodal clinical and molecular data with a robust suite of AI tools to help physicians personalize care in real time, connect patients with therapies and clinical trials, and enable partners to accelerate discovery and development of new treatments. With ~8 million de-identified research records and 350+ petabytes of data, Tempus partners...
GoodRx is America’s healthcare marketplace. Each month, millions of people visit goodrx.com to find reliable health information and discounts for their healthcare — and we’ve helped people save $35 billion since 2011. We provide prescription discounts that are accepted at more than 70,000 pharmacies in the U.S., as well as telehealth services including doctor visits and lab tests. Our goal is...
Babylist is the trusted platform for millions of growing families. For over a decade, Babylist has been the technology solution for expecting parents and the community that supports them, expanding from baby registry into a full-service platform that helps parents make decisions with confidence, stay connected, and build happy and healthy families. Every year Babylist helps over 9M people make...
Babylist's Top Stability & Growth Strengths
Strong Revenue Growth: Recent disclosures indicate 2025 revenue surpassed $750 million with 45% year‑over‑year growth, with outlook commentary noting sales approaching $1 billion in 2026. This trajectory reflects accelerating scale across the business.
Profitability: The company reports eight consecutive years of profitability. Business press coverage reinforces this sustained profitable profile alongside rapid scaling.
Diversified Revenue Streams: Management emphasizes health services and media as incremental growth vectors, with third‑party coverage noting strong 2025 growth in both areas. Babylist Health’s first‑year traction (including large volumes of insurance‑covered breast pump shipments) underscores revenue diversity beyond core registry commerce.
Pulse Biosciences is the inventor and sole proprietor of Nanosecond Pulsed Field Ablation™ (nsPFA™) technology. We are committed to health innovation that has the potential to improve and extend the lives of patients. Our proprietary Nanosecond Pulsed Field Ablation technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue. The people at Pulse Biosciences are...
Teladoc Health is on a mission to empower all people everywhere to live healthier lives by transforming the healthcare experience. Recognized as the world leader in whole-person virtual care, Teladoc Health addresses the full spectrum of health and well-being — powered by human expertise, advanced technology and insights—to deliver improved clinical outcomes at scale. Serving more than 175 countries and...
We are on a mission to make healthcare personalized, accessible and easier for all of us as consumers. Our Intelligent Personalization Layer enables leading healthcare organizations and payers build deeper and richer connections with their members, driving engagement, satisfaction and improved outcomes. With RadiantGraph you can reduce data engineering spend while bringing new ideas, experiments, and clinical interventions forward, in less...
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Illumina's Top Stability & Growth Strengths
Strong Market Position & Advantage: Feedback suggests Illumina maintains dominant leadership in short-read NGS with a broad installed base, end-to-end workflows, and wide adoption across research and clinical markets. This entrenched position supports recurring consumables pull-through and reinforces competitive advantage.
Profitability: Feedback suggests profitability and margins improved with a stronger year-end quarter, rising EPS, and robust free cash generation supporting restructuring and reinvestment. Operating performance strengthened year over year, indicating better cost discipline and a healthier earnings profile.
Innovation-Driven Growth: Feedback suggests product and technology innovation—including NovaSeq X adoption and advances in AI/informatics—is driving utilization and clinical momentum. Partnerships and acquisitions broaden multiomics capabilities and underpin a roadmap focused on further cost and throughput gains.
The only culturally-authentic virtual care platform that provides unlimited, immediate, and affordable access to fully-bilingual US-licensed health professionals. MiSalud Health’s mission to provide affordable and culturally-authentic medical care for underserved communities in the US is backed by: Magnify Ventures, Chris Sacca's Lowercase Capital, Ulu Ventures, and Rise Capital.
